Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Johnson and Johnson
Moodys
Dow
Express Scripts

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206099

See Plans and Pricing

« Back to Dashboard

NDA 206099 describes ONZETRA XSAIL, which is a drug marketed by Currax and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug. Additional details are available on the ONZETRA XSAIL profile page.

The generic ingredient in ONZETRA XSAIL is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
Summary for 206099
Tradename:ONZETRA XSAIL
Applicant:Currax
Ingredient:sumatriptan succinate
Patents:17
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 206099
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099 NDA Avanir Pharmaceuticals, Inc. 64597-311 64597-311-08 1 KIT in 1 CARTON (64597-311-08) * 8 POUCH in 1 CARTON > 2 CAPSULE in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;NASALStrengthEQ 11MG BASE
Approval Date:Jan 27, 2016TE:RLD:Yes
Patent:  Start TrialPatent Expiration:Oct 20, 2034Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:Jul 30, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:ACUTE TREATMENT OF MIGRAINE BY DELIVERING A POWDERED SUBSTANCE COMPRISING SUMATRIPTAN VIA A BREATH-POWERED DELIVERY DEVICE
Patent:  Start TrialPatent Expiration:Jul 30, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF DELIVERING SUMATRIPTAN TO A NASAL CAVITY

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
McKesson
Dow
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.